Editas Medicine Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Editas Medicine Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Cambridge
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: EDIT
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001650664
EIN: 46-4097528
Wikidata ID: Q23131313

Board of directors

Follow this board

Akshay Vaishnaw · Director
Since 2023
Andrew Hirsch · Director
Since 2023
Bernadette Connaughton · Director
Since 2023
David Scadden · Director
Since 2023
Elliott M. Levy · Director
Since 2023
Emma Reeve · Director
Since 2023
Gilmore Neil O'Neill · Director · CEO
Since 2023
Jessica Hopfield · Director
Since 2023
Meeta Chatterjee · Director
Since 2023
Patrick Thomas Ellinor II · Director
Since 2026

Chief executives

Gilmore Neil O'Neill · CEO

Dates unknown

Board connections

8 of this board's directors also sit on 11 other boards. 11 are in the same sector.

Shared director Other board Same sector

Agios Pharmaceuticals Inc. Same sector
via David Scadden
C4 Therapeutics Inc. Same sector
via Andrew Hirsch
Halozyme Therapeutics Inc. Same sector
via Bernadette Connaughton
Hemab Therapeutics Holdings Inc. Same sector
via Akshay Vaishnaw
Insulet Corporation Same sector
via Jessica Hopfield
Maravai LifeSciences Holdings Inc. Same sector
via Jessica Hopfield
NuCana plc American Depositary Share Same sector
via Elliott M. Levy
PTC Therapeutics Inc. Same sector
via Emma Reeve
Scholar Rock Holding Corporation Same sector
via Akshay Vaishnaw
Werewolf Therapeutics Inc. Same sector
via Meeta Chatterjee
Whitehawk Therapeutics Inc. Same sector
via Emma Reeve

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $106,706; 14 sales by 3 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 5, 2026	Burkly Linda Officer (EVP, CHIEF SCIENTIFIC OFFICER)	Grant or award	+16,533	—	—
Nov 5, 2026	Gilmore Neil O'Neill Director, Officer (CEO)	Grant or award	+43,567	—	—
Sep 3, 2026	Burkly Linda Officer (EVP, CHIEF SCIENTIFIC OFFICER)	Open-market sale	−709	$3.04	$2,155
Sep 3, 2026	Gilmore Neil O'Neill Director, Officer (CEO)	Open-market sale	−5,124	$3.04	$15,577
Sep 3, 2026	Parison Amy Officer (SVP, Chief Financial Officer)	Open-market sale	−453	$3.04	$1,377
Aug 3, 2026	Parison Amy Officer (SVP, Chief Financial Officer)	Open-market sale	−678	$2.58	$1,749
Jul 28, 2026	Burkly Linda Officer (EVP, CHIEF SCIENTIFIC OFFICER)	Open-market sale	−4,928	$2.67	$13,158
Jun 3, 2026	Parison Amy Officer (SVP, Chief Financial Officer)	Open-market sale	−464	$2.70	$1,253
Jun 3, 2026	Gilmore Neil O'Neill Director, Officer (CEO)	Open-market sale	−15,380	$2.70	$41,526
Jun 3, 2026	Burkly Linda Officer (EVP, CHIEF SCIENTIFIC OFFICER)	Open-market sale	−731	$2.70	$1,974
Mar 3, 2026	Gilmore Neil O'Neill Director, Officer (CEO)	Open-market sale	−5,394	$2.02	$10,896
Mar 3, 2026	Parison Amy Officer (SVP, Chief Financial Officer)	Open-market sale	−474	$2.02	$957
Mar 3, 2026	Burkly Linda Officer (EVP, CHIEF SCIENTIFIC OFFICER)	Open-market sale	−749	$2.02	$1,513
Dec 3, 2025	Burkly Linda Officer (EVP, CHIEF SCIENTIFIC OFFICER)	Open-market sale	−713	$2.15	$1,533
Dec 3, 2025	Gilmore Neil O'Neill Director, Officer (CEO)	Open-market sale	−5,603	$2.15	$12,046

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Editas Medicine Inc.

Who is the CEO of Editas Medicine Inc.?

Gilmore Neil O'Neill is Editas Medicine Inc.'s CEO.

How many directors are on Editas Medicine Inc.'s board?

Editas Medicine Inc.'s board has 10 directors: Akshay Vaishnaw, Andrew Hirsch, Bernadette Connaughton, David Scadden, Elliott M. Levy, Emma Reeve, Gilmore Neil O'Neill, Jessica Hopfield, Meeta Chatterjee and Patrick Thomas Ellinor II.

Are Editas Medicine Inc. insiders buying or selling shares?

Over the last 12 months, Editas Medicine Inc. insiders made no open-market purchases and sold $106,706 of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Editas Medicine Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="editas-medicine-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.